Home › NDC Lookup › RxCUI directory › RxCUI 205751

Gemfibrozil 600 MG Oral Tablet [Lopid] — RxCUI 205751

RxNorm drug concept · Semantic branded drug
RxCUI 205751 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI205751
Official nameGemfibrozil 600 MG Oral Tablet [Lopid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLopid 600 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gemfibrozil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on why your doctor prescribed it. For most people, it's either bringing down dangerously high triglycerides — the type that can cause pancreatitis — or, in a specific gr...
  • What exactly is gemfibrozil supposed to do for me?
  • Yes, timing actually matters with this one. You take it twice a day — once about 30 minutes before breakfast and once about 30 minutes before your evening meal. Taking it before yo...
  • When should I take it and does it matter if I take it with food?
📖 Read our full Gemfibrozil guide →

🕸️ Concept Web — How Gemfibrozil 600 MG Oral Tablet [Lopid] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Gemfibrozil 600 MG Oral Tablet [Lopid] RxCUI 205751

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gemfibrozil 4719
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lopid 202999
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gemfibrozil Oral Tablet 372300
    • Gemfibrozil Oral Product 1163944
    • Gemfibrozil Pill 1163945
    • Gemfibrozil Oral Tablet [Lopid] 369510
    • Lopid Oral Product 1179662
    • Lopid Pill 1179663
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Gemfibrozil 600 MG Oral Tablet SCD · 310459
  • Gemfibrozil 600 MG SCDC · 317636
  • Gemfibrozil Oral Tablet SCDF · 372300
  • Gemfibrozil Oral Product SCDG · 1163944
  • Gemfibrozil Pill SCDG · 1163945

Brand-Name Concepts

  • Gemfibrozil 600 MG [Lopid] SBDC · 566639
  • Gemfibrozil Oral Tablet [Lopid] SBDF · 369510
  • Lopid Oral Product SBDG · 1179662
  • Lopid Pill SBDG · 1179663
  • Lopid BN · 202999

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 205751 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00071-0737-20 60 TABLET, FILM COATED in 1 BOTTLE (0071-0737-20) Lopid Parke-Davis Div of Pfizer Inc 2004-03-30
00071-0737-30 500 TABLET, FILM COATED in 1 BOTTLE (0071-0737-30) Lopid Parke-Davis Div of Pfizer Inc 2004-03-30
Observed labelers: Parke-Davis Div of Pfizer Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.